in this issue
People & Business :: Companies
BASF Offers Broader Technology Base
11:25 AM MDT | July 27, 2007 | Alex Scott
BASF’s acquisition of Orgamol more than one year ago significantly boosted BASF’s offering to pharma fine chemical customers, adding a suite of specialist technologies including azide chemistry, low-temperature chemistry, and halogenation reactions, says Martin Widmann, head of BASF’s Pharma Solutions global business unit. The integration of Orgamol into the BASF group is completed, BASF says. Overall sales in BASF’s standard active pharma ingredients business declined during 2006, however, due particularly to a previously announced...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee